Company / Operating Income per Share
BridgeBio Pharma, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.75
FY2025
5-year range
-$3.83 / -$2.17
FY2021-FY2025
Trend
+18.7%
vs FY2024
Sector context
#136 of 201
Health Care
What the data says
At $-2.75, BridgeBio Pharma, Inc.'s operating income per share ranks #136 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 9 years, ranging from $-3.84 in FY2020 to $-1.43 in FY2017.
Based on SEC 10-K filings.
-2.75 in FY2025.
Improved from $-3.83 to $-2.75 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#136 of 201 in Health CareTop 68% of 201This company -$2.75 Sector average -$3.23
▼
+14.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 18.7% year-over-year.
- Ranks #136 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.75 | +18.7% |
| FY2024 | -$3.39 | +11.5% |
| FY2023 | -$3.83 | -10.1% |
| FY2022 | -$3.48 | -60.4% |
| FY2021 | -$2.17 | +43.5% |
| FY2020 | -$3.84 | -32.7% |
| FY2019 | -$2.89 | +2.7% |
| FY2018 | -$2.97 | -107.4% |
| FY2017 | -$1.43 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026